Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health
Deloitte
Farmers Insurance
Express Scripts
UBS
Fuji
Citi
McKesson
US Army

Generated: August 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076884

« Back to Dashboard
NDA 076884 describes ALCLOMETASONE DIPROPIONATE, which is a drug marketed by Glenmark Generics, Taro, and Fougera Pharms, and is included in six NDAs. It is available from five suppliers. Additional details are available on the ALCLOMETASONE DIPROPIONATE profile page.

The generic ingredient in ALCLOMETASONE DIPROPIONATE is alclometasone dipropionate. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alclometasone dipropionate profile page.

Summary for NDA: 076884

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)

Pharmacology for NDA: 076884

Suppliers and Packaging for NDA: 076884

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALCLOMETASONE DIPROPIONATE
alclometasone dipropionate
OINTMENT;TOPICAL 076884 ANDA E. Fougera & Co., a division of Fougera Pharmaceuticals Inc. 0168-0264 0168-0264-15 1 TUBE in 1 CARTON (0168-0264-15) > 15 g in 1 TUBE
ALCLOMETASONE DIPROPIONATE
alclometasone dipropionate
OINTMENT;TOPICAL 076884 ANDA E. Fougera & Co., a division of Fougera Pharmaceuticals Inc. 0168-0264 0168-0264-45 1 TUBE in 1 CARTON (0168-0264-45) > 45 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.05%
Approval Date:Jul 18, 2005TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
QuintilesIMS
Chinese Patent Office
Mallinckrodt
UBS
Julphar
Johnson and Johnson
Daiichi Sankyo
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot